Brendan P. Eckelman
2020
In 2020, Brendan P. Eckelman earned a total compensation of $589.7K as Chief Scientific Officer at Inhibrx, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $195,082 |
|---|---|
| Salary | $390,000 |
| Other | $4,667 |
| Total | $589,749 |
Eckelman received $390K in salary, accounting for 66% of the total pay in 2020.
Eckelman also received $195.1K in non-equity incentive plan and $4.7K in other compensation.
Rankings
In 2020, Brendan P. Eckelman's compensation ranked 10,558th out of 13,090 executives tracked by ExecPay. In other words, Eckelman earned more than 19.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,558 out of 13,090 | 19th |
Division Manufacturing | 4,530 out of 5,624 | 20th |
Major group Chemicals And Allied Products | 1,882 out of 2,257 | 17th |
Industry group Drugs | 1,648 out of 1,957 | 16th |
Industry Biological Products, Except Diagnostic Substances | 374 out of 411 | 9th |
Source: SEC filing on April 28, 2021.
Eckelman's colleagues
We found three more compensation records of executives who worked with Brendan P. Eckelman at Inhibrx in 2020.